Mice immunization with Trypanosoma brucei gambiense translationally controlled tumor protein modulates immunoglobulin and cytokine production, as well as parasitaemia and mice survival after challenge with the parasite.

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Géraldine BossardAnne Geiger

Abstract

Fighting trypanosomiasis with an anti-trypanosome vaccine is ineffective, the parasite being protected by a Variable Surface Glycoprotein (VSG) whose structure is modified at each peak of parasitaemia, which allows it to escape the host's immune defenses. However, the host immunization against an essential factor for the survival of the parasite or the expression of its pathogenicity could achieve the same objective. Here we present the results of mouse immunization against the Translationally Controlled Tumor Protein (TCTP), a protein present in the Trypanosoma brucei gambiense (Tbg) secretome, the parasite responsible for human trypanosomiasis. Mice immunization was followed by infection with Tbg parasites. The production of IgG, IgG1 and IgG2a begun after the second TCTP injection and was dose-dependant, the maximum level of anti-TCTP antibodies remained stable up to 4 days post-infection and then decreased. Regarding cytokines (IL-2, 4, 6, 10, INFγ, TNFα), the most striking result was their total suppression after immunization with the highest TCTP dose. Compared to the control group, the immunized mice displayed a reduced first peak of parasitaemia, a 100% increase in the time to onset of the second peak, and an increased ...Continue Reading

References

Aug 15, 2002·Transactions of the Royal Society of Tropical Medicine and Hygiene·V LejonP Büscher
Feb 21, 2003·European Journal of Immunology·Meiqing ShiHenry Tabel
Dec 23, 2003·The International Journal of Biochemistry & Cell Biology·Ulrich-Axel Bommer, Bernd-Joachim Thiele
Apr 26, 2006·Immunome Research·Jens Erik Pontoppidan LarsenMorten Nielsen
Feb 16, 2008·Cell Death and Differentiation·L SusiniA Telerman
Jan 7, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Martin GuilliamsAlain Beschin
Dec 17, 2009·Journal of Biomedicine & Biotechnology·Celestine Michelle Atyame NtenAnne Geiger
Jan 28, 2010·BMC Microbiology·Anne GeigerJean-Benoit Peltier
Aug 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Florian BrioudesMohammed Bendahmane
Feb 24, 2016·Development·Cláudio Gouveia RoqueChristine E Holt
Oct 23, 2016·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Geraldine BossardPhilippe Holzmuller
Jun 2, 2017·Trends in Parasitology·Alba CortésRafael Toledo

❮ Previous
Next ❯

Related Concepts

Related Feeds

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.